GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders
July 5, 2023
Ryan Allway July 5th, 2023 News, Top News, Top Story BALTIMORE, July 05, 2023 (GLOBE NEWSWIRE) — Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that it has been granted final approval for... Read more
Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections
August 10, 2022
Ryan Allway August 10th, 2022 News, Top News ARDS-003 is a novel therapeutic for acute systemic inflammation and prevention of acute respiratory distress syndrome (ARDS). ARDS-003 may offer steroid-sparing opportunities. ARDS-003 has demonstrated antiviral properties. ARDS-003 developed as an oral formulation for an immediate release administration. OTTAWA, ON, Aug. 10,... Read more
